We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+4.64%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$26.1B
AUM Growth
+$1.03B
Cap. Flow
-$146M
Cap. Flow %
-0.56%
Top 10 Hldgs %
13.61%
Holding
1,470
New
112
Increased
493
Reduced
531
Closed
130

Top Buys

Rank Stock Value
1
TEL icon
TE Connectivity
TEL
+$94.2M
2
MDT icon
Medtronic
MDT
+$83.5M
3
VZ icon
Verizon
VZ
+$54.1M
4
ADBE icon
Adobe
ADBE
+$54.1M
5
AMZN icon
Amazon
AMZN
+$50.7M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$81.3M
2
ST icon
Sensata Technologies
ST
+$78M
3
PCG icon
PG&E
PCG
+$52M
4
AMGN icon
Amgen
AMGN
+$43.5M
5
LOW icon
Lowe's Companies
LOW
+$40.5M

Sector Composition

Rank Sector Weight
1 Technology 22.67%
2 Healthcare 15.83%
3 Consumer Discretionary 11.21%
4 Financials 11.2%
5 Industrials 8.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APEI icon
1326
American Public Education
APEI
$813M
– –
-18,000
Closed -$774K
AVNS
1327
DELISTED
Avanos Medical
AVNS
– –
-34,100
Closed -$1.57M
BC icon
1328
Brunswick
BC
$4.54B
– –
-7,300
Closed -$434K
BCO icon
1329
Brink's
BCO
$4.5B
– –
-3,990
Closed -$285K
BHB icon
1330
Bar Harbor Bankshares
BHB
$682M
– –
-10,317
Closed -$286K
CAKE icon
1331
Cheesecake Factory
CAKE
$5.23B
– –
-13,700
Closed -$661K
CECO icon
1332
Ceco Environmental
CECO
$4.14B
– –
-73,100
Closed -$325K
CLDX icon
1333
Celldex Therapeutics
CLDX
$3.08B
– –
-18,607
Closed -$650K
CNMD icon
1334
CONMED
CNMD
$1.39B
– –
-12,560
Closed -$795K
COKE icon
1335
Coca-Cola Consolidated
COKE
$13.4B
– –
-43,000
Closed -$742K
CTO
1336
CTO Realty Growth
CTO
$782M
– –
-11,789
Closed -$201K
CWT icon
1337
California Water Service
CWT
$2.98B
– –
-8,600
Closed -$320K
DBRG icon
1338
DigitalBridge
DBRG
$2.98B
– –
-4,075
Closed -$91K
DHX icon
1339
DHI Group
DHX
$208M
– –
-73,800
Closed -$118K
DIN icon
1340
Dine Brands
DIN
$367M
– –
-6,300
Closed -$413K
EPP icon
1341
iShares MSCI Pacific ex Japan ETF
EPP
$2.27B
– –
-63,692
Closed -$2.96M
ESPR
1342
DELISTED
Esperion Therapeutics
ESPR
– –
-4,700
Closed -$340K
EWC icon
1343
iShares MSCI Canada ETF
EWC
$6.85B
– –
-26,258
Closed -$724K
EWD icon
1344
iShares MSCI Sweden ETF
EWD
$738M
– –
-10,003
Closed -$335K
EWL icon
1345
iShares MSCI Switzerland ETF
EWL
$2.32B
– –
-13,900
Closed -$478K
EWU icon
1346
iShares MSCI United Kingdom ETF
EWU
$3.72B
– –
-33,200
Closed -$1.15M
EWY icon
1347
iShares MSCI South Korea ETF
EWY
$26.9B
– –
-3,998
Closed -$302K
FET icon
1348
Forum Energy Technologies
FET
$926M
– –
-9,565
Closed -$2.1M
KYNB
1349
Kyntra Bio
KYNB
$32.5M
– –
-244
Closed -$282K
FIZZ icon
1350
National Beverage
FIZZ
$2.98B
– –
-11,400
Closed -$507K
52 53
54
55 56

Similar funds

VI
Ventas Inc Chicago, Illinois $91.9M AUM 27.96% 1-Year Est. Return
FA
Forefront Analytics West Conshohocken, Pennsylvania $92M AUM 25.18% 1-Year Est. Return
PBCM
Point Break Capital Management Miami, Florida $91.7M AUM
CCAM
Crystal Cove Asset Management Newport Beach, California $91.7M AUM
GBA
Garrison Bradford & Associates New York $92.2M AUM 19.08% 1-Year Est. Return
AWP
Atlas Wealth Partners Wyomissing, Pennsylvania $91.6M AUM 9.52% 1-Year Est. Return
HI
Hyundai Investments Yeongdeungopo-Gu, Seoul, South Korea $92.3M AUM 0.12% 1-Year Est. Return
DCA
DB&C Advisors Holland, Michigan $92.4M AUM

Axa's Q2 2018 Portfolio in Review

As of Q2 2018, Axa held 1,470 positions worth $26.1B, up 4.1% from $25.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Axa's Q2 2018 filing shows 112 new, 493 increased, 531 reduced and 130 closed positions. Its largest new stake was Foot Locker: 289,100 shares worth $15.2M. The largest sale was AbbVie, an estimated $81.3M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q2 2018 buy was Foot Locker: 289,100 shares worth $15.2M.
  • Axa added most to TE Connectivity in Q2 2018, an estimated $94.2M increase.
  • Axa's biggest Q2 2018 reduction was AbbVie, cutting an estimated $81.3M.
  • Axa fully exited PG&E in Q2 2018, selling an estimated $52M.
  • Axa's ten largest holdings make up 14% of its $26.1B portfolio in Q2 2018.
  • Axa opened 112 new positions and closed 130 in Q2 2018.
  • Axa's portfolio value rose 4.1% quarter-over-quarter to $26.1B.

Based on Axa's 13F filing for Q2 2018, filed 13 Aug 2018.